An emergency medicine-focused review of malignant otitis externa

Published:April 29, 2020DOI:https://doi.org/10.1016/j.ajem.2020.04.083

      Abstract

      Introduction

      Malignant otitis externa (MOE) is a progressive infection of the external auditory canal (EAC). This disease is rare but has severe morbidity and mortality.

      Objective

      This narrative review provides an overview of malignant otitis externa for emergency clinicians.

      Discussion

      MOE is an invasive external ear infection that spreads to the temporal bone and can further progress to affect intracranial structures. Complications of advanced MOE include cranial nerve involvement, most commonly the facial nerve, and intracranial infections such as abscess and meningitis. The most common causative agent of MOE is Pseudomonas aeruginosa, but others include methicillin-resistant Staphylococcus aureus and fungi. Major risk factors for MOE include diabetes mellitus, immunosuppression, and advanced age. Red flags for MOE include severe otalgia (pain out of proportion to exam) or severe otorrhea, neurologic deficits (especially facial nerve involvement), previously diagnosed otitis externa not responsive to therapy, and patients with major risk factors for MOE. Examination may show purulent otorrhea or granulation tissue in the EAC, and culture of EAC drainage should be performed. Diagnosis is aided by computed tomography (CT) with intravenous contrast, which may demonstrate bony destruction of the temporal bone or skull base. When suspecting MOE, early consultation with an otolaryngologist is recommended and antibiotics with pseudomonal coverage are needed. Most patients with MOE will require admission to the hospital.

      Conclusions

      MOE is a rare, yet deadly diagnosis that must be suspected when patients with immunocompromise, diabetes, or advanced age present with severe otalgia. Rapid diagnosis and treatment may prevent complications and improve outcomes.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Schuknecht H.F.
        Pathology of the ear.
        2nd ed. Lea & Febiger, Philadelphia1993: 220-223
        • Meltzer P.E.
        • Kelemen G.
        Pyocutaneous osteomyelitis of the temporal bone, mandible, and zygoma.
        Laryngoscope. 1959; 169: 1300-1316
        • Chandler J.R.
        Malignant external otitis.
        Laryngoscope. 1968; 78: 1257-1294
        • Nadol Jr., J.B.
        Histopathology of pseudomonas osteomyelitis of the temporal bones starting as malignant external otitis.
        Am J Otolaryngol. 1980; 1: 359-371
        • Carfrae M.J.
        • Kesser B.W.
        Malignant otitis externa.
        Otolaryngol Clin North Am. 2008 Jun; 41 ([viii-ix]): 537-549
        • Khan M.A.
        • Quadri S.A.Q.
        • Kazmi A.S.
        • et al.
        A comprehensive review of skull base osteomyelitis: diagnostic and therapeutic challenges among various presentations.
        Asian J Neurosurg. 2018 Oct-Dec; 13: 959-970
        • Sreepada G.S.
        • Kwartler J.A.
        Skull base osteomyelitis secondary to malignant otitis externa.
        Curr Opin Otolaryngol Head Neck Surg. 2003; 11: 316-323
        • Schwarz G.A.
        • Blumenkrantz M.J.
        • Sundmäker W.L.
        Neurologic complications of malignant external otitis.
        Neurology. 1971; 21: 1077-1084
        • Glikson E.
        • Sagiv D.
        • Wolf M.
        • Shapira Y.
        Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series.
        Diagn Microbiol Infect Dis. 2017; 87: 74-78
        • Bramer W.M.
        • Rethlefsen M.L.
        • Kleijnen J.
        • Franco O.H.
        Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study.
        Syst Rev. 2017; 6: 245
        • Waldvogel F.A.
        • Medoff G.
        • Swartz M.N.
        Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects.
        N Engl J Med. 1970; 282 (Jan 22): 198-206
        • Kaya I.
        • Sezgin B.
        • Eraslan S.
        • et al.
        Malignant otitis externa: a retrospective analysis and treatment outcomes.
        Turk Arch Otorhinolaryngol. 2018; 56 (Jun): 106-110
        • Mani N.
        • Sudhoff H.
        • Rajagopal S.
        • et al.
        Cranial nerve involvement in malignant external otitis: implications for clinical outcome.
        Laryngoscope. 2007; 117: 907
        • Chen C.N.
        • Chen Y.S.
        • Yeh T.H.
        • Hsu C.J.
        • Tseng F.Y.
        Outcomes of malignant external otitis: survival vs mortality.
        Acta Otolaryngol. 2010; 130: 89-94
        • Slattery W.H.
        • Brackmann D.E.
        Skull base osteomyelitis: malignant otitis externa.
        Otolaryngol Clin North Am. 1996; 29: 795-806
        • Giamarellou H.
        Malignant otitis externa: the therapeutic evolution of a lethal infection.
        J Antimicrob Chemother. 1992; 30: 745-751
        • Favero M.S.
        • Carson L.A.
        • Bond W.W.
        • Petersen N.J.
        Pseudomonas aeruginosa: growth in distilled water from hospitals.
        Science. 1971; 173: 836
        • Salit I.E.
        • Miller B.
        • Wigmore M.
        • Smith J.A.
        Bacterial flora of the external canal in diabetics and non-diabetics.
        Laryngoscope. 1982; 92: 672
        • Rubin J.
        • Yu V.L.
        Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy.
        Am J Med. 1988; 85: 391-398
        • Jacobsen L.M.
        • Antonelli P.J.
        Errors in the diagnosis and management of necrotizing otitis externa.
        Otolaryngol Head Neck Surg. 2010; 143: 506-509
        • Hobson C.E.
        • Moy J.D.
        • Byers K.E.
        • et al.
        Malignant otitis externa: evolving pathogens and implications for diagnosis and treatment.
        Otolaryngol Head Neck Surg. 2014; 151 (Jul): 112-116
        • Lee S.K.
        • Lee S.A.
        • Seon S.W.
        • et al.
        Analysis of prognostic factors in malignant external otitis.
        Clin Exp Otorhinolaryngol. 2017; 10 (Sep): 228-235
        • Hern J.D.
        • Almeyda J.
        • Thomas D.M.
        • et al.
        Malignant otitis externa in HIV and AIDS.
        J Laryngol Otol. 1996; 110: 770-775
        • Yao M.
        • Messner A.H.
        Fungal malignant otitis externa due to Scedosporium apiospermum.
        Ann Otol Rhinol Laryngol. 2001; 110: 377-380
        • Hamzany Y.
        • Soudry E.
        • Preis M.
        • et al.
        Fungal malignant external otitis.
        J Infect. 2011; 62 (Mar): 226-231
        • Cunningham M.
        • Yu V.L.
        • Turner J.
        • et al.
        Necrotizing otitis externa due to Aspergillus in an immunocompetent patient.
        Arch Otolaryngol Head Neck Surg. 1988; 114: 554-556
        • Menachof M.R.
        • Jackler R.K.
        Otogenic skull base osteomyelitis caused by invasive fungal infection.
        Otolaryngol Head Neck Surg. 1990; 102: 285-289
        • Blyth C.C.
        • Gomes L.
        • Sorrell T.C.
        • et al.
        Skull base osteomyelitis: fungal vs. bacterial.
        Clin Microbiol Infect. 2011 Feb; 17: 306-311
        • Berenholz L.
        • Katzenell U.
        • Harell M.
        Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa.
        Laryngoscope. 2002; 112: 1619-1622
        • Levenson M.J.
        • Parisier S.C.
        • Dolitsky J.
        • et al.
        Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
        Laryngoscope. 1991; 101: 821-824
        • Djalilian H.R.
        • Shamloo B.
        • Thakkar K.H.
        • Najme-Rahim M.
        Treatment of culture-negative skull base osteomyelitis.
        Otol Neurotol. 2006; 27 (Feb): 250-255
        • Naghibi M.
        • Smith R.P.
        • Baltch A.L.
        • et al.
        The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes.
        Diabetes Res Clin Pract. 1987; 4: 27-35
        • Geerlings S.E.
        • Hoepelman A.I.
        Immune dysfunction in patients with diabetes mellitus (DM).
        FEMS Immunol Med Microbiol. 1999; 26: 259-265
        • Babiatzki A.
        • Sade J.
        Malignant external otitis.
        J Laryngol Otol. 1987; 101: 205-210
        • Unadkat S.
        • Kanzara T.
        • Watters G.
        Necrotizing otitis externa in the immunocompetent patient: case series.
        J Laryngol Otol. 2018 Jan; 132: 71-74
        • Sylvester M.J.
        • Sanghvi S.
        • Patel V.M.
        • et al.
        Malignant otitis externa hospitalizations: analysis of patient characteristics.
        Laryngoscope. 2017; 127 (Oct): 2328-2336
        • Soudry E.
        • Hamzany Y.
        • Preis M.
        • Joshua B.
        • Hadar T.
        • Nageris B.I.
        Malignant external otitis: analysis of severe cases.
        Otolaryngol Head Neck Surg. 2011; 144: 758-762
        • Castro R.
        • Robinson N.
        • Klein J.
        • et al.
        Malignant external otitis and mastoiditis associated with an IgG4 subclass deficiency in a child.
        Del Med J. 1990; 62: 1417-1421
        • Paul A.C.
        • Justus A.
        • Balraj A.
        • et al.
        Malignant otitis externa in an infant with selective IgA deficiency: a case report.
        Int J Pediatr Otorhinolaryngol. 2001; 60: 141-145
        • Sobie S.
        • Brodsky L.
        • Stanievich J.F.
        Necrotizing external otitis in children: report of two cases and review of the literature.
        Laryngoscope. 1987; 97598–601
        • Wolff L.J.
        Necrotizing otitis externa during induction therapy for acute lymphoblastic leukemia.
        Pediatrics. 1989; 84: 882-885
        • Tezcan I.
        • Tuncer A.M.
        • Yenicesu I.
        • et al.
        Necrotizing otitis externa, otitis media, peripheral facial paralysis, and brain abscess in a thalassemic child after allogeneic BMT.
        Pediatr Hematol Oncol. 1998; 15: 459-462
        • Rubin J.
        • Yu V.L.
        • Stool S.E.
        Malignant external otitis in children.
        J Pediatr. 1998; 113: 965-970
        • Mahdyoun P.
        • Pulcini C.
        • Gahide I.
        • Raffaelli C.
        • Savoldelli C.
        • Castillo L.
        • et al.
        Necrotizing otitis externa: a systematic review.
        Otol Neurotol. 2013; 34: 620-629
        • Marina S.
        • Goutham M.K.
        • Rajeshwary A.
        • et al.
        A retrospective review of 14 cases of malignant otitis externa.
        J Otol. 2019 Jun; 14: 63-66
        • Courson A.M.
        • Vikram H.R.
        • Barrs D.M.
        What are the criteria for terminating treatment for necrotizing (malignant) otitis externa?.
        Laryngoscope. 2014; 124 (Feb): 361-362
        • Hasibi M.
        • Ashtiani M.K.
        • Motassadi Z.M.
        • et al.
        A treatment protocol for management of bacterial and fungal malignant external otitis: a large cohort in Tehran, Iran.
        Ann Otol Rhinol Laryngol. 2017 Jul; 126: 561-567
        • Adams A.
        • Offiah C.
        Central skull base osteomyelitis as a complication of necrotizing otitis externa: imaging findings, complications, and challenges of diagnosis.
        Clin Radiol. 2012; 67: e7-e16
        • Ress B.D.
        • Luntz M.
        • Telischi F.F.
        • et al.
        Necrotizing external otitis in patients with AIDS.
        Laryngoscope. 1997; 107: 456-460
        • Bhandary S.
        • Karki P.
        • Sinha B.K.
        Malignant otitis externa: a review.
        Pac Health Dialog. 2002; 9: 64-67
        • Hopkins R.J.
        • Bergeson P.S.
        • Pinckard K.C.
        • et al.
        Otitis externa posing as mastoiditis.
        Arch Pediatr Adolesc Med. 1994 Dec; 148: 1346-1349
        • Russell J.D.
        • Donnelly M.
        • McShane D.P.
        • et al.
        What causes acute otitis externa?.
        J Laryngol Otol. 1993; 107: 898
        • Centers for Disease Control and Prevention (CDC)
        Estimated burden of acute otitis externa—United States, 2003-2007.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 605-609
        • Aguis A.M.
        • Pickles J.M.
        • Burch K.L.
        A prospective study of otitis externa.
        Clin Otolaryngol Allied Sci. 1992; 17: 150
        • Rosenfeld R.M.
        • Schwartz S.R.
        • Cannon C.R.
        • et al.
        Clinical practice guideline: acute otitis externa [published correction appears in Otolaryngol Head Neck Surg. 2014 Mar;150(3):504].
        . 2014; 150: S1-S24
        • Beers S.L.
        • Abramo T.J.
        Otitis externa review.
        Pediatr Emerg Care. 2004; 20: 250
        • Laurikainen E.
        • Puhakka H.
        • Rikalainen H.
        Coincidental radiographic findings in severe external otitis in non-immunocompromised patients.
        ORL J Otorhinolaryngol Relat Spec. 1990; 52: 391-394
        • Lewis K.
        • Cherry J.
        Mastoiditis.
        in: Feigin L. Cherry J. Textbook of pediatric infectious diseases. 3rd ed. WB Saunders Co, Philadelphia, Pa1992: 189-195
        • Pritchett C.V.
        • Thorne M.C.
        Incidence of pediatric acute mastoiditis.
        Arch Otolaryngol Head Neck Surg. 2012 May; 138: 451-455
        • Smith J.A.
        • Danner C.J.
        Complications of chronic otitis media and cholesteatoma.
        Otolaryngol Clin North Am. 2006; 39: 1237
        • van den Aardweg M.T.
        • Rovers M.M.
        • de Ru J.A.
        • et al.
        A systematic review of diagnostic criteria for acute mastoiditis in children.
        Otol Neurotol. 2008; 29: 751
        • Thorne M.C.
        • Chewaproug L.
        • Elden L.M.
        Suppurative complications of acute otitis media: changes in frequency over time.
        Arch Otolaryngol Head Neck Surg. 2009; 135: 638-641
        • Majeed J.
        • Sudarshan Reddy L.
        Role of CT mastoids in the diagnosis and surgical management of chronic inflammatory ear diseases.
        Indian J Otolaryngol Head Neck Surg. 2017; 69 (Mar): 113-120
        • Combacchio F.
        • D’ Eredita R.
        • Biron E.
        • et al.
        Follow up of necrotizing external otitis.
        Acta Otorhinolaryngol. 1993; 13517Y524
        • Rubin J.
        • Stoehr G.
        • Yu V.L.
        • et al.
        Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis.
        Arch Otolaryngol Head Neck Surg. 1989; 115 (Sep): 1063-1069
        • Brar T.
        • Mrig S.
        • Passey J.C.
        • et al.
        Complicated coexisting pyogenic and tuberculous otitis media affecting the temporozygomatic, infratemporal, and parotid areas: report of a rare entity.
        Ear Nose Throat J. 2013 Jan; 92: E10-E12
        • Hwang G.H.
        • Jung J.Y.
        • Yum G.
        • Choi J.
        Tuberculous otitis media with facial paralysis combined with labyrinthitis.
        Korean J Audiol. 2013 Apr; 17: 27-29
        • Van Kroonenburgh A.M.J.L.
        • van der Meer W.L.
        • Bothof R.J.P.
        • et al.
        Advanced imaging techniques in skull base osteomyelitis due to malignant otitis externa.
        Curr Radiol Rep. 2018; 6: 3
        • Parisier S.C.
        • Lucente F.E.
        • Som P.M.
        • et al.
        Nuclear scanning in necrotizing progressive “malignant” external otitis.
        Laryngoscope. 1982; 92: 1016-1019
        • Grandis J.R.
        • Curtin H.D.
        • Yu V.L.
        Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up.
        Radiology. 1995; 196: 499-504
        • Franco-Vidal V.
        • Blanchet H.
        • Bebear C.
        • Dutronc H.
        • Darrouzet V.
        Necrotizing external otitis: a report of 46 cases.
        Otol Neurotol. 2007; 28: 771-773
        • Grandis J.R.
        • Branstetter B.F.T.
        • Yu V.L.
        The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations.
        Lancet Infect Dis. 2004; 4: 34-39
        • Lesser F.D.
        • Derbyshire S.G.
        • Lewis-Jones H.
        Can computed tomography and magnetic resonance imaging differentiate between malignant pathology and osteomyelitis in the central skull base?.
        J Laryngol Otol. 2015; 129: 852-859
        • Kwon B.J.
        • Han M.H.
        • Oh S.H.
        • et al.
        MRI findings and spreading patterns of necrotizing external otitis: is a poor outcome predictable?.
        Clin Radiol. 2006; 61: 495-504
        • Casey S.O.
        • Alberico R.A.
        • Patel M.
        • et al.
        Cerebral CT venography.
        Radiology. 1996; 198: 163
        • Majoie C.B.
        • van Straten M.
        • Venema H.W.
        • den Heeten
        Multisection CT venography of the dural sinuses and cerebral veins by using matched mask bone elimination.
        AJNR Am J Neuroradiol. 2004; 25: 787
        • Rizzo L.
        • Crasto S.G.
        • Ruda R.
        • et al.
        Cerebral venous thrombosis: role of CT, MRI and MRA in the emergency setting.
        Radiol Med. 2010; 115: 313
        • Dormont D.
        • Anxionnat R.
        • Evrard S.
        • et al.
        MRI in cerebral venous thrombosis.
        J Neuroradiol. 1994; 21: 81
        • Coutinho J.M.
        • Stam J.
        How to treat cerebral venous and sinus thrombosis.
        J Thromb Haemost. 2010; 8: 877
        • Einhaupl K.M.
        • Villringer A.
        • Meister W.
        • et al.
        Heparin treatment in sinus venous thrombosis.
        Lancet. 1991; 338: 597
        • Stam J.
        • De Bruijn S.F.
        • DeVeber G.
        Anticoagulation for cerebral sinus thrombosis.
        Cochrane Database Syst Rev. 2002; 4: CD002005
        • Stam J.
        Thrombosis of the cerebral veins and sinuses.
        N Engl J Med. 2005; 352: 1791
        • Medel R.
        • Monteith S.J.
        • Crowley R.W.
        • Dumont A.S.
        A review of therapeutic strategies for the management of cerebral venous sinus thrombosis.
        Neurosurg Focus. 2009; 27 (Nov): E6
        • Rahman M.
        • Velat G.J.
        • Hoh B.L.
        • Mocco J.
        Direct thrombolysis for cerebral venous sinus thrombosis.
        Neurosurg Focus. 2009; 27 (Nov): E7
        • Ekseth K.
        • Bostrom S.
        • Vegfors M.
        Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report.
        Neurosurgery. 1998; 43 (Oct): 960-965
        • Cohen D.
        • Friedman P.
        The diagnostic criteria of malignant externa otitis.
        J Laryngol Otol. 1987; 101 (Mar): 216-221
        • Thakar A.
        • Kacker S.K.
        • Bahadur S.
        Malignant external otitis.
        Ind J Otolaryngol Head Neck Surg. 1996; 48: 114Y120
        • Stevens S.M.
        • Lambert P.R.
        • Baker A.B.
        • Meyer T.A.
        Malignant otitis externa: a novel stratification protocol for predicting treatment outcomes.
        Otol Neurotol. 2015; 36 (Sep): 1492-1498
        • Soudry E.
        • Joshua B.Z.
        • Sulkes J.
        • Nageris B.I.
        Characteristics and prognosis of malignant external otitis with facial paralysis.
        Arch Otolaryngol Head Neck Surg. 2007 Oct; 133: 1002-1004
        • Karaiskos I.
        • Lagou S.
        • Pontikis K.
        • et al.
        The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how.
        Front Public Health. 2019; 7: 151
        • Lodise Jr., T.P.
        • Lomaestro B.
        • Drusano G.L.
        Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.
        Clin Infect Dis. 2007; 44: 357
        • Rossolini G.M.
        • Mantengoli E.
        Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
        Clin Microbiol Infect. 2005; 11: 17
        • Tunkel A.R.
        • Hasbun R.
        • Bhimraj A.
        • et al.
        2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.
        Clin Infect Dis. 2017 Mar 15; 64: e34-e65
        • Bodilsen J.
        • Brouwer M.C.
        • Nielsen H.
        • Van De Beek D.
        Anti-infective treatment of brain abscess.
        Expert Rev Anti Infect Ther. 2018; 16: 565-578
        • Kountakis S.E.
        • Kemper Jr., J.V.
        • Chang C.Y.
        • et al.
        Osteomyelitis of the base of the skull secondary to Aspergillus.
        Am J Otolaryngol. 1997; 18: 19-22
        • Stodulski D.
        • Kowalska B.
        • Stankiewicz C.
        Otogenic skull base osteomyelitis caused by invasive fungal infection: case report and literature review.
        Eur Arch Otorhinolaryngol. 2006; 263: 1070-1076
        • Walton J.
        • Coulson C.
        Fungal malignant otitis externa with facial nerve palsy: tissue biopsy AIDS diagnosis.
        Case Rep Otolaryngol. 2014; 2014192318
        • Mion M.
        • Bovo R.
        • Marchese-Ragona R.
        • Martini A.
        Outcome predictors of treatment effectiveness for fungal malignant external otitis: a systematic review.
        Acta Otorhinolaryngol Ital. 2015; 35: 307
        • Parize P.
        • Chandesris M.O.
        • Lanternier F.
        • et al.
        Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
        Antimicrob Agents Chemother. 2009; 53 (Mar): 1048-1053
        • Al-Doussary S.
        • Attalah M.
        • Al Rahab A.
        • et al.
        Otitis externa malignant. A case report and review of literature.
        Otolaryngol Pol. 1998; 52: 19Y22
        • Bath A.P.
        • Rowe J.R.
        • Innes A.J.
        Clinical records malignant otitis externa with optic neuritis.
        J Laryngol Otol. 1998; 112: 274Y277
        • Phillips J.S.
        • Jones S.E.
        Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa.
        Cochrane Database Syst Rev. 2013 May 31; 5: CD004617
      Advertisement